“…However, the expansion of A. subrufescens ‐related technologies appears to be limited (Largeteau et al ., ). First, few commercial cultivars are currently available and these showed high genetic homogeneity (Colauto et al ., ; Fukuda et al ., ; Mahmud et al ., ; Tomizawa et al ., ) raising the issue of crop health and the economic risks related to disease susceptibility of a monocrop. Secondly, although an extensive literature is available on its pharmacological interest (Firenzuoli et al ., ; Oliveira et al ., ; Wisitrassameewong et al ., ), studies on its ecology, reproductive biology, biodiversity and genetics are scarce (Kerrigan, ; Largeteau et al ., ).…”